ZyLET
Active Ingredient(s): Loteprednol + TobramycinFDA Approved: * December 14, 2004
Pharm Company: * BAUSCH AND LOMB
Category: Vision / Eye Health
Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax[1] and Loterex. It was patented in 1980 and approved for medical use in 1998.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 5.3 Retrometabolic drug design 6 Chemistry 6.1 Chemical synthesis 7 References 8 Furt... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
